Sera Prognostics, Inc. (SERA) stock
SERANasdaqServices-Medical LaboratoriesFiscal year ends December 31
$2.00+0.06 (+3.09%)
Close on Nov 17, 2026Market cap $78.90MP/E –Yield –
Sera Prognostics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Sera Prognostics's operating cash flow for the twelve months ending Jun 30, 2026 was -$27.68M. For fiscal 2025 it was -$25.62M. The highest annual figure on record is -$14.19M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$25.62M | – |
| FY2024 | Dec 31, 2024 | -$14.19M | – |
| FY2023 | Dec 31, 2023 | -$27.19M | – |
| FY2022 | Dec 31, 2022 | -$34.61M | – |
| FY2021 | Dec 31, 2021 | -$31.64M | – |
| FY2020 | Dec 31, 2020 | -$16.87M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$6.31M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.77M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.12M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.48M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.47M | – |
| Q1 FY2025 | Mar 31, 2025 | -$7.55M | -251.2% |
| Q4 FY2024 | Dec 31, 2024 | -$6.26M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.00M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.93M | – |
| Q1 FY2024 | Mar 31, 2024 | $4.99M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.77M | – |
| Q3 FY2023 | Sep 30, 2023 | -$7.59M | – |
| Q2 FY2023 | Jun 30, 2023 | -$7.95M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.88M | – |
| Q4 FY2022 | Dec 31, 2022 | -$7.24M | – |
| Q3 FY2022 | Sep 30, 2022 | -$8.78M | – |
| Q2 FY2022 | Jun 30, 2022 | -$9.04M | – |
| Q1 FY2022 | Mar 31, 2022 | -$9.56M | – |
| Q4 FY2021 | Dec 31, 2021 | -$9.15M | – |
| Q3 FY2021 | Sep 30, 2021 | -$9.30M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.24M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.95M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.19M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.92M | – |
See a number that looks wrong?